Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.270
-0.090 (-3.81%)
At close: Apr 22, 2026, 4:00 PM EDT
2.200
-0.070 (-3.08%)
After-hours: Apr 22, 2026, 7:57 PM EDT
Daré Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts that cover Daré Bioscience stock have a consensus rating of "Strong Buy" and an average price target of $10, which forecasts a 340.53% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $12.
Price Target: $10 (+340.53%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 2, 2025.
Analyst Ratings
The average analyst rating for Daré Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +428.63% | Dec 2, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +252.42% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +428.63% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +428.63% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +428.63% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
22.82M
from 1.03M
Increased by 2,115.12%
Revenue Next Year
50.80M
from 22.82M
Increased by 122.62%
EPS This Year
-0.65
from -1.20
EPS Next Year
0.93
from -0.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 59.4M | 99.0M | ||||||
| Avg | 22.8M | 50.8M | ||||||
| Low | 532,140 | 5.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5,666.3% | 333.7% | ||||||
| Avg | 2,115.1% | 122.6% | ||||||
| Low | -48.3% | -77.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.29 | 1.85 | ||||||
| Avg | -0.65 | 0.93 | ||||||
| Low | -1.66 | 0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.